Original paper

COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance

Volume: 12, Issue: 1
Published: Jun 23, 2021
Abstract
While mass-scale vaccination campaigns are ongoing worldwide, genomic surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical to monitor the emergence and global spread of viral variants of concern (VOC). Here, we present a streamlined workflow—COVseq—which can be used to generate highly multiplexed sequencing libraries compatible with Illumina platforms from hundreds of SARS-CoV-2 samples in parallel, in a rapid...
Paper Details
Title
COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance
Published Date
Jun 23, 2021
Volume
12
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.